These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 23495791)
1. Bacterial lipid modification enhances immunoprophylaxis of filarial abundant larval transcript-2 protein in Mastomys model. Sharmila S; Christiana I; Kiran P; Reddy MV; Sankaran K; Kaliraj P Parasite Immunol; 2013 Jul; 35(7-8):201-13. PubMed ID: 23495791 [TBL] [Abstract][Full Text] [Related]
2. The adjuvant-free immunoprotection of recombinant filarial protein Abundant Larval Transcript-2 (ALT-2) in Mastomys coucha and the immunoprophylactic importance of its putative signal sequence. Sharmila S; Christiana I; Kiran P; Reddy MV; Kaliraj P Exp Parasitol; 2011 Nov; 129(3):247-53. PubMed ID: 21864531 [TBL] [Abstract][Full Text] [Related]
3. Epitope mapping of Brugia malayi ALT-2 and the development of a multi-epitope vaccine for lymphatic filariasis. Madhumathi J; Prince PR; Rao DN; Karande AA; Reddy MV; Kaliraj P J Helminthol; 2017 Jan; 91(1):43-54. PubMed ID: 26892175 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of Brugia malayi Abundant Larval Transcript-2, a potential filarial vaccine candidate expressed in tobacco. Ganapathy M; Perumal A; Mohan C; Palaniswamy H; Perumal K Plant Cell Rep; 2014 Jan; 33(1):179-88. PubMed ID: 24277081 [TBL] [Abstract][Full Text] [Related]
5. Immunization with a multisubunit vaccine considerably reduces establishment of infective larvae in a rodent model of Brugia malayi. Shrivastava N; Singh PK; Nag JK; Kushwaha S; Misra-Bhattacharya S Comp Immunol Microbiol Infect Dis; 2013 Sep; 36(5):507-19. PubMed ID: 23829972 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis. Vanam U; Pandey V; Prabhu PR; Dakshinamurthy G; Reddy MV; Kaliraj P Am J Trop Med Hyg; 2009 Feb; 80(2):319-24. PubMed ID: 19190232 [TBL] [Abstract][Full Text] [Related]
7. Single multivalent vaccination boosted by trickle larval infection confers protection against experimental lymphatic filariasis. Joseph SK; Ramaswamy K Vaccine; 2013 Jul; 31(33):3320-6. PubMed ID: 23735679 [TBL] [Abstract][Full Text] [Related]
8. Prospects of developing a prophylactic vaccine against human lymphatic filariasis - evaluation of protection in non-human primates. Khatri V; Chauhan N; Vishnoi K; von Gegerfelt A; Gittens C; Kalyanasundaram R Int J Parasitol; 2018 Aug; 48(9-10):773-783. PubMed ID: 29885437 [TBL] [Abstract][Full Text] [Related]
9. Dissecting the Immune Response Elicited by WbALT-2, ALT MAP in Clinical Populations and Mouse Model: A Prophylactic Measure Against Lymphatic Filariasis. Ramanathan A; Immanuel C; Rao DN; Kaliraj P Lymphat Res Biol; 2015 Jun; 13(2):120-5. PubMed ID: 26091407 [TBL] [Abstract][Full Text] [Related]
10. Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model. Thirugnanam S; Pandiaraja P; Ramaswamy K; Murugan V; Gnanasekar M; Nandakumar K; Reddy MV; Kaliraj P Exp Parasitol; 2007 Aug; 116(4):483-91. PubMed ID: 17442307 [TBL] [Abstract][Full Text] [Related]
11. Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (ALT-2) and thioredoxin peroxidase (TPX) in mice. Anand SB; Murugan V; Prabhu PR; Anandharaman V; Reddy MV; Kaliraj P Acta Trop; 2008 Aug; 107(2):106-12. PubMed ID: 18547532 [TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of nematode specific protective epitopes of Brugia malayi TRX towards development of synthetic vaccine construct for lymphatic filariasis. Madhumathi J; Prince PR; Anugraha G; Kiran P; Rao DN; Reddy MV; Kaliraj P Vaccine; 2010 Jul; 28(31):5038-48. PubMed ID: 20653106 [TBL] [Abstract][Full Text] [Related]
13. The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis. Gregory WF; Atmadja AK; Allen JE; Maizels RM Infect Immun; 2000 Jul; 68(7):4174-9. PubMed ID: 10858234 [TBL] [Abstract][Full Text] [Related]
15. Structural modelling studies and immunoprophylactic potential of Brugia malayi DEAD Box RNA helicase. Singh M; Shrivastava N; Saqib U; Siddiqi MI; Misra-Bhattacharya S Parasitology; 2013 Jul; 140(8):1016-25. PubMed ID: 23743239 [TBL] [Abstract][Full Text] [Related]
16. Vaccination with 73kDa recombinant heavy chain myosin generates high level of protection against Brugia malayi challenge in jird and mastomys models. Vedi S; Dangi A; Hajela K; Misra-Bhattacharya S Vaccine; 2008 Nov; 26(47):5997-6005. PubMed ID: 18817835 [TBL] [Abstract][Full Text] [Related]
17. Multivalent fusion protein vaccine for lymphatic filariasis. Dakshinamoorthy G; Samykutty AK; Munirathinam G; Reddy MV; Kalyanasundaram R Vaccine; 2013 Mar; 31(12):1616-22. PubMed ID: 23036503 [TBL] [Abstract][Full Text] [Related]
18. Evaluating the efficacy of rBmHATαc as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation. Dakshinamoorthy G; Kalyanasundaram R Vaccine; 2013 Dec; 32(1):19-25. PubMed ID: 24211167 [TBL] [Abstract][Full Text] [Related]
19. Chimeric Epitope Vaccine from Multistage Antigens for Lymphatic Filariasis. Anugraha G; Madhumathi J; Prince PR; Prita PJ; Khatri VK; Amdare NP; Reddy MV; Kaliraj P Scand J Immunol; 2015 Oct; 82(4):380-9. PubMed ID: 26179420 [TBL] [Abstract][Full Text] [Related]
20. Immunization with inflammatory proteome of Brugia malayi adult worm induces a Th1/Th2-immune response and confers protection against the filarial infection. Sahoo MK; Sisodia BS; Dixit S; Joseph SK; Gaur RL; Verma SK; Verma AK; Shasany AK; Dowle AA; Murthy PK Vaccine; 2009 Jul; 27(32):4263-71. PubMed ID: 19450648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]